Canine Parvovirus Vaccine (MLV)
For the vaccination of healthy dogs against disease due to canine Parvovirus. Designed to be used primarily where the severe threat of canine Parvovirus infections exists in the resident dog population. Inject 1 mL subcutaneously or intramuscularly into healthy dogs. Administer the initial dose at or about 42 days of age. Revaccinate every 14 to 21 days until the dog is 18 weeks or age. Revaccinate annually with one dose.
Do not use on pregnant dogs.
Any use of a product that is not clearly defined on the label directions should only be done under supervision of a qualified veterinary professional.
View manufacturer and/or label information
All vaccines are labeled - "Use entire contents when first opened".
You May Also Like